Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papilloma Virus Infection Type 6”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Large-scale testing (Phase 3)Study completedNCT02576054
What this trial is testing

Safety and Tolerability Study of V501 in Japanese Boys (V501-200)

Who this might be right for
Anogenital Human Papilloma Virus InfectionCondyloma Acuminata
Merck Sharp & Dohme LLC 101
Not applicableUnknownNCT01427777
What this trial is testing

3-year Immunogenicity Evaluation of Quadrivalent HPV Vaccine in China

Who this might be right for
Anogenital Human Papilloma Virus Infection
Guangxi Center for Disease Control and Prevention 300
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Testing effectiveness (Phase 2)UnknownNCT02710851
What this trial is testing

Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Who this might be right for
Condylomata Acuminata
Jun Zhang 640
Large-scale testing (Phase 3)Study completedNCT00157950
What this trial is testing

Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 176
Large-scale testing (Phase 3)Looking for participantsNCT05027776
What this trial is testing

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 1,348
Not applicableStudy completedNCT02551887
What this trial is testing

HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+4 more
Regenstrief Institute, Inc. 647
Very early researchStudy completedNCT02546752
What this trial is testing

Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+2 more
Regenstrief Institute, Inc. 1,306
Early research (Phase 1)Study completedNCT02405520
What this trial is testing

Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Who this might be right for
Condylomata Acuminata
Jun Zhang 145
Large-scale testing (Phase 3)Study completedNCT00090220
What this trial is testing

Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)

Who this might be right for
Healthy Adult Female ParticipantsPreventionPapillomavirus Infection+1 more
Merck Sharp & Dohme LLC 3,819
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Testing effectiveness (Phase 2)Study completedNCT05694728
What this trial is testing

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papilloma Virus Infection
Beijing Health Guard Biotechnology, Inc 780
Not applicableStudy completedNCT02558803
What this trial is testing

HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+4 more
Regenstrief Institute, Inc. 1,305
Early research (Phase 1)Ended earlyNCT00798265
What this trial is testing

A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

Who this might be right for
Human Immunodeficiency VirusHuman Papillomavirus- 6, 11, 16, 18Adolescent+1 more
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Study completedNCT02114385
What this trial is testing

Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020)

Who this might be right for
Papilloma Viral Infection
Merck Sharp & Dohme LLC 500
Early research (Phase 1)Study completedNCT03900572
What this trial is testing

Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine

Who this might be right for
HPV Infections
Shanghai Zerun Biotechnology Co.,Ltd 90
Not applicableUnknownNCT01298869
What this trial is testing

The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Chronic Kidney Disease, Stage IV (Severe)Chronic Kidney Disease, Stage V
Chulalongkorn University 60
Large-scale testing (Phase 3)Study completedNCT00735462
What this trial is testing

Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts

Who this might be right for
Genital Warts
Graceway Pharmaceuticals, LLC 511